Innoviva (INVA) Other Non-Current Liabilities (2010 - 2026)
Innoviva (INVA) reported Other Non-Current Liabilities of $67.28 million for Q2 2026, up 12.1% from $60.02 million a year earlier but down 2.6% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
At the end of FY2025, Innoviva posted Other Non-Current Liabilities of $66.09 million, up 2.8% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 262.2% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $64.28 million in FY2024 (-10.6%), $71.87 million in FY2023 (+1.3%) and $70.92 million in FY2022.
- Five-year quarterly Other Non-Current Liabilities spans a low of $14,000 in Q3 2021 and a high of $72.07 million in Q2 2024.
- Year over year, Other Non-Current Liabilities has now increased in each of the last three quarters, with an average decline of 4.9% over the last seven quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q2 2026 (growth of 12.1%); the low point was Q3 2021 (a decline of 89.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $69.1 million (Q1 2026), $66.09 million (Q4 2025) and $57.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Innoviva | 1.54 Bn | -753.32 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.28 Mn |
| Mar 31, 2026 | 69.10 Mn |
| Dec 31, 2025 | 66.09 Mn |
| Sep 30, 2025 | 57.43 Mn |
| Jun 30, 2025 | 60.02 Mn |
| Mar 31, 2025 | 62.01 Mn |
| Dec 31, 2024 | 64.28 Mn |
| Sep 30, 2024 | 71.45 Mn |
| Jun 30, 2024 | 72.07 Mn |
| Mar 31, 2024 | 71.69 Mn |
| Dec 31, 2023 | 71.87 Mn |
| Sep 30, 2023 | 68.69 Mn |
| Jun 30, 2023 | 68.58 Mn |
| Mar 31, 2023 | 70.13 Mn |
| Dec 31, 2022 | 70.92 Mn |
| Sep 30, 2022 | 78.42 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 3.30 Mn |
| Sep 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 45,000.00 |
API Access
Innoviva Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();